Managing Nocturia and Atrial Fibrillation Risks

This chapter delves into the evaluation and management of nocturia, outlining its mechanisms and conservative treatment strategies before pharmacotherapy. Additionally, it introduces the HARMS 2 AF risk score for assessing atrial fibrillation risk and discusses the efficacy of Zolendronate in fracture prevention.